Kuvatris Therapeutics, Inc.
PXMDDelisted Aug 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811623
Kuvatris Therapeutics, Inc. was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Mar 14, 2024; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Kuvatris Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 8 | 13 | +5 |
| Shares | 210.9K | 296.2K | +85.3K (+40.5%) |
| Value | $165.3K | $85.8K | −$79.5K (−48.1%) |
New holders (6)
Institutions that held Kuvatris Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 97,100 | $28.0K | 0.00% |
| Clearstead Advisors, LLC | 38,156 | $10.9K | 0.00% |
| Susquehanna International Group, LLP | 31,034 | $9.22K | 0.00% |
| Advisor Group Holdings, Inc. | 2,000 | $572 | 0.00% |
| UBS Group AG | 1,098 | $314 | 0.00% |
| JPMorgan Chase & Co | 4 | $1 | 0.00% |
Sold out (1)
Institutions that held Kuvatris Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Citadel Advisors LLC | 68,991 | $54.2K |